You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Imbruvica

Showing 26 - 50 of 146
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia Trial in Milano (Venetoclax, Imbruvica Oral Product)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Milano, MI, Italy
    Ospedale San Raffaele
Apr 2, 2022

Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • +7 more
  • (no location specified)
Jun 21, 2022

Lung Cancer Trial in Houston (Ibrutinib)

Completed
  • Lung Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 21, 2021

Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Sacramento (Ibrutinib, Nivolumab)

Completed
Has Results
  • Metastatic Renal Cell Cancer
  • Stage IV Renal Cell Cancer
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 8, 2022

Chronic Lymphocytic Leukemia Trial in Columbus (biological, drug, other)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Daratumumab
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Recruiting
  • Chronic Graft vs Host Disease
    • Bucheon-Si, Korea, Republic of
    • +9 more
    Jan 27, 2023

    Chronic Lymphocytic Leukemia Trial in Boston, Hackensack, New York (Ublituximab, Umbralisib, Ibrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Boston, Massachusetts
    • +2 more
    Aug 19, 2022

    Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +6 more
    • New York, New York
      Weill Cornell Medicine
    Dec 21, 2021

    Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

    Active, not recruiting
    • Stage I Chronic Lymphocytic Leukemia
    • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Mar 24, 2022

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

    Not yet recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 10, 2022

    Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guandong, Guangzhou (Methotrexate, Ibrutinib, Temozolomide)

    Recruiting
    • Primary Central Nervous System Lymphoma
    • +2 more
    • Guandong, Guangdong, China
    • +2 more
    Apr 6, 2022

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small

    Recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +4 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Mar 22, 2022

    Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

    Recruiting
    • Ann Arbor Stage II Follicular Lymphoma
    • +5 more
    • Fresno, California
    • +2 more
    Jan 24, 2023

    Chronic Lymphocytic Leukemia Trial in Cologne (Ibrutinib, Placebo)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Cologne, Germany
      German CLL Study Group
    Dec 16, 2021

    Chronic Lymphocytic Leukemia, Loss of Chromosome 17p Trial (Ibrutinib, Venetoclax)

    Withdrawn
    • Chronic Lymphocytic Leukemia
    • Loss of Chromosome 17p
    • (no location specified)
    Oct 29, 2021

    Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,

    Withdrawn
    • Asymptomatic COVID-19 Infection Laboratory-Confirmed
    • +8 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 2, 2022

    Relapsed DLBCL, Refractory DLBCL Trial in Hackensack (ABT-199, Ibrutinib, Rituximab)

    Active, not recruiting
    • Relapsed Diffuse Large B-Cell Lymphoma
    • Refractory Diffuse Large B-Cell Lymphoma
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Oct 7, 2022

    Chronic Lymphocytic Leukemia Trial in Boston, Rochester, Durham (Obinutuzumab, Ibrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Boston, Massachusetts
    • +3 more
    Jan 3, 2022

    Loss of Chromosome 17p, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

    Completed
    • Loss of Chromosome 17p
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 4, 2022

    Aplastic Anemia, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Columbus (Best Practice, Ibrutinib)

    Active, not recruiting
    • Aplastic Anemia
    • +6 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 24, 2022

    Mantle Cell Lymphoma Trial in Hackensack (Lenalidomide, Ibrutinib, Rituximab)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Hackensack, New Jersey
      The Cancer Center at Hackensack University Medical Center
    May 3, 2022

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Portland (Ibrutinib, Obinutuzumab)

    Completed
    Has Results
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Dec 10, 2021

    Relapsed/Refractory Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Leukemia Trial in Switzerland (Ibrutinib,

    Active, not recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • +2 more
    • Aarau, Switzerland
    • +10 more
    Mar 10, 2022

    Hematologic Malignancy Trial in United States (BBI608, Dexamethasone, Bortezomib)

    Completed
    • Hematologic Malignancy
    • Denver, Colorado
    • +7 more
    Apr 4, 2022

    Chronic Lymphocytic Leukemia, Leukemia Trial in United States (Ibrutinib, Fludarabine, Cyclophosphamide)

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Leukemia
    • Coral Gables, Florida
    • +8 more
    Sep 28, 2022